(Q33744042)

29 July 2017

1 reference

title

Paediatric HIV-1 infection (English)

1 reference

29 July 2017

D N Burns

1

1 reference

29 July 2017

L M Mofenson

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

354 Suppl 2

1 reference

29 July 2017

page(s)

SII1-6

1 reference

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Trends in perinatal transmission of HIV/AIDS in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Short-course zidovudine for prevention of perinatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Cost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries. Ghent International Working Group on Mother-to-Child Transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

The incidence of complications after caesarean section in 156 HIV-positive women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Use of multivitamin/mineral prenatal supplements: influence on the outcome of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Chlorhexidine vaginal irrigation for the prevention of peripartal infection: a placebo-controlled randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Chorioamnionitis and pregnancy outcome in HIV-infected African women. Pregnancy and HIV Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Cell-free human immunodeficiency virus type 1 in breast milk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Benefits of HIV screening of blood transfusions in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Model-Based Estimates of the Risk of Human Immunodeficiency Virus and Hepatitis B Virus Transmission through Unsafe Injections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Increased protected sex and abstinence among Namibian youth following a HIV risk-reduction intervention: a randomized, longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Reductions in risk behaviour provide the most consistent explanation for declining HIV-1 prevalence in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Thymic dysfunction and time of infection predict mortality in human immunodeficiency virus-infected infants. CDC Perinatal AIDS Collaborative Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Differential tropism of HIV-1 isolates for distinct thymocyte subsets in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobuli

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Virologic and immunologic response to nucleoside reverse-transcriptase inhibitor therapy among human immunodeficiency virus-infected infants and children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2990249-0

7 January 2021

10.1016/S0140-6736(99)90249-0

Identifiers

DOI

1 reference

release_mnr5osxgknarvfmi543ictv2rm

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mnr5osxgknarvfmi543ictv2rm

24 November 2022

mapped directly with Wikidata item

1 reference